Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

All but one Senate Republican voted for Kennedy, a controversial vaccine critic whose embrace of the “Make America Healthy ...

Three stocks that may be underrated options for dividend investors to consider today are PepsiCo ( PEP 0.41%), United Parcel ...

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. “In 2024 we achieved our third year of constant currency revenue growth and delivered ...

Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.

Tuesday, the agency signed off on SpringWorks’ Gomekli (mirdametinib) as a treatment for the rare genetic disorder ...